Effect of Intranasal Mupirocin on Rate of Staphylococcus Aureus Surgical Site Infection Following Cesarean Sections

Hillel Yaffe Medical Center

Status: Unknown

Conditions: Cesarean Section; Staphylococcus Aureus; Surgical Wound Infection

Treatments: Drug: Mupirocin

Study type: Interventional

Funder types: Other

Identifiers

NCT01152593

HYMC0033-10

Details and patient eligibility

About

The investigators believe that irradication of nose colonization of staphyloccocus aureus will reduce the incidence of surgical site infections after cesarean section.

Enrollment: 400 estimated patients

Sex: Female

Volunteers: No Healthy Volunteers

Inclusion criteria

• Women assigned to undergo cesarean section

Exclusion criteria

• All others

Trial design

Primary purpose: Prevention

Allocation: Randomized

Interventional model: Single Group Assignment

Masking: None (Open label)

---

400 participants in 1 patient group

Intranasal Mupirocin

Experimental group

Treatment:

Drug: Mupirocin